Evolent Health Stock Performance
| EVH Stock | USD 4.15 0.13 3.23% |
The firm shows a Beta (market volatility) of 1.03, which means a somewhat significant risk relative to the market. Evolent Health returns are very sensitive to returns on the market. As the market goes up or down, Evolent Health is expected to follow. At this point, Evolent Health has a negative expected return of -0.96%. Please make sure to confirm Evolent Health's maximum drawdown, as well as the relationship between the accumulation distribution and day typical price , to decide if Evolent Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Evolent Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return 3.23 | Five Day Return 3.49 | Year To Date Return 6.68 | Ten Year Return (64.25) | All Time Return (78.00) |
1 | Inspire Medical Systems Tops Q3 Earnings and Revenue Estimates | 11/03/2025 |
2 | Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know | 11/11/2025 |
3 | Acquisition by Springstubb Brendan B of 10000 shares of Evolent Health at 3.8199 subject to Rule 16b-3 | 11/18/2025 |
4 | Stocks making big moves yesterday Cogent, Wix, WESCO, LGI Homes, and Evolent Health | 11/20/2025 |
5 | Stocks making big moves yesterday Meta, Tenet Healthcare, Wynn Resorts, Elevance Health, and Merck | 11/25/2025 |
6 | Stocks making big moves this week Deere, Marvell Technology, Elevance Health, Align Technology, and Tenet Healthcare | 11/28/2025 |
7 | Evolent Health, Inc EVH Shares Acquired by XTX Topco Ltd | 12/02/2025 |
8 | Maverick Capital Ltd. Invests 15.68 Million in Evolent Health, Inc EVH | 12/12/2025 |
9 | Evolent Health Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in MedicareMedicaid Membership | 12/16/2025 |
10 | Evolent Health Sells ACO Unit, Strengthens Balance Sheet | 12/22/2025 |
11 | Evolent Health Stock Price Crosses Below 50-Day Moving Average Heres Why | 01/02/2026 |
12 | Insider Stock Buying Reaches US1.38m On Evolent Health | 01/07/2026 |
| Begin Period Cash Flow | 223.5 M | |
| Total Cashflows From Investing Activities | -62.9 M |
Evolent Health Relative Risk vs. Return Landscape
If you would invest 794.00 in Evolent Health on October 10, 2025 and sell it today you would lose (379.00) from holding Evolent Health or give up 47.73% of portfolio value over 90 days. Evolent Health is generating negative expected returns assuming volatility of 4.4455% on return distribution over 90 days investment horizon. In other words, 39% of stocks are less volatile than Evolent, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Evolent Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evolent Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Evolent Health, and traders can use it to determine the average amount a Evolent Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2152
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EVH |
Based on monthly moving average Evolent Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evolent Health by adding Evolent Health to a well-diversified portfolio.
Evolent Health Fundamentals Growth
Evolent Stock prices reflect investors' perceptions of the future prospects and financial health of Evolent Health, and Evolent Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evolent Stock performance.
| Return On Equity | -0.12 | ||||
| Return On Asset | 0.0012 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 1.41 B | ||||
| Shares Outstanding | 111.6 M | ||||
| Price To Earning | (13.88) X | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 0.23 X | ||||
| Revenue | 2.55 B | ||||
| Gross Profit | 378.34 M | ||||
| EBITDA | 84.85 M | ||||
| Net Income | (61.62 M) | ||||
| Cash And Equivalents | 104.2 M | ||||
| Cash Per Share | 1.57 X | ||||
| Total Debt | 713.67 M | ||||
| Debt To Equity | 0.56 % | ||||
| Current Ratio | 1.03 X | ||||
| Book Value Per Share | 7.55 X | ||||
| Cash Flow From Operations | 18.77 M | ||||
| Earnings Per Share | (1.57) X | ||||
| Market Capitalization | 481.28 M | ||||
| Total Asset | 2.54 B | ||||
| Retained Earnings | (780.82 M) | ||||
| Working Capital | (108.38 M) | ||||
| Current Asset | 184.46 M | ||||
| Current Liabilities | 59.51 M | ||||
About Evolent Health Performance
By evaluating Evolent Health's fundamental ratios, stakeholders can gain valuable insights into Evolent Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Evolent Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Evolent Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 78.67 | 82.61 | |
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.07) | (0.07) |
Things to note about Evolent Health performance evaluation
Checking the ongoing alerts about Evolent Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Evolent Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Evolent Health generated a negative expected return over the last 90 days | |
| Evolent Health has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 2.55 B. Reported Net Loss for the year was (61.62 M) with profit before taxes, overhead, and interest of 378.34 M. | |
| Evolent Health has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Insider Stock Buying Reaches US1.38m On Evolent Health |
- Analyzing Evolent Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evolent Health's stock is overvalued or undervalued compared to its peers.
- Examining Evolent Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Evolent Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evolent Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Evolent Health's stock. These opinions can provide insight into Evolent Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |